Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma

被引:0
|
作者
Hay-Ran Jang
Sol-Bi Shin
Chang-Hyeon Kim
Jae-Yeon Won
Rong Xu
Da-Eun Kim
Hyungshin Yim
机构
[1] Hanyang University,Department of Pharmacy, College of Pharmacy
[2] Hanyang University,Institute of Pharmaceutical Science and Technology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2106 / 2106
相关论文
共 50 条
  • [1] PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
    Jang, Hay-Ran
    Shin, Sol-Bi
    Kim, Chang-Hyeon
    Won, Jae-Yeon
    Xu, Rong
    Kim, Da-Eun
    Yim, Hyungshin
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (09): : 2745 - 2764
  • [2] PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma
    Hay-Ran Jang
    Sol-Bi Shin
    Chang-Hyeon Kim
    Jae-Yeon Won
    Rong Xu
    Da-Eun Kim
    Hyungshin Yim
    Cell Death & Differentiation, 2021, 28 : 2745 - 2764
  • [3] PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma (Aug, 10.1038/s41418-021-00842-8, 2021)
    Jang, Hay-Ran
    Shin, Sol-Bi
    Kim, Chang-Hyeon
    Won, Jae-Yeon
    Xu, Rong
    Kim, Da-Eun
    Yim, Hyungshin
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (10): : 2106 - 2106
  • [4] Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma
    Zhang, Yan
    Du, Weiwei
    Chen, Zhaoliang
    Xiang, Cheng
    EXPERIMENTAL CELL RESEARCH, 2017, 359 (02) : 449 - 457
  • [5] PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
    Stein, Alexander
    Simnica, Donjete
    Schultheiss, Christoph
    Scholz, Rebekka
    Tintelnot, Joseph
    Goekkurt, Eray
    von Wenserski, Lisa
    Willscher, Edith
    Paschold, Lisa
    Sauer, Markus
    Lorenzen, Sylvie
    Riera-Knorrenschild, Jorge
    Depenbusch, Reinhard
    Ettrich, Thomas J.
    Doerfel, Steffen
    Al-Batran, Salah-Eddin
    Karthaus, Meinolf
    Pelzer, Uwe
    Waberer, Lisa
    Hinke, Axel
    Bauer, Marcus
    Massa, Chiara
    Seliger, Barbara
    Wickenhauser, Claudia
    Bokemeyer, Carsten
    Hegewisch-Becker, Susanna
    Binder, Mascha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [6] KRAS mutation- induced upregulation of PD-L1 mediates immune escape in lung adenocarcinoma
    Hong, S.
    Chen, N.
    Fang, W.
    Zhan, J.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Inhibition of c-MET upregulates PD-L1 related immune escape in lung adenocarcinoma
    Sun, Xian
    Li, Chia-Wei
    Wang, Wei-Jan
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [8] BATF-Activated AIM2 Mediates Immune Escape in Lung Adenocarcinoma by Regulating PD-L1
    Liu, Xiang
    Zhou, Wangyan
    Zheng, Dayang
    Yang, Xu
    Qing, Yongcheng
    Liao, Weijun
    Zeng, Wei
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024,
  • [9] Glutathione S-transferase omega 2 regulates PD-L1 expression and immune escape of lung adenocarcinoma
    Sumiya, Ryusuke
    Hatano, Hiroto
    Yamada, Kazuhiko
    Kokudo, Norihiro
    Kawamura, Yuki I.
    CANCER SCIENCE, 2025, 116 : 213 - 213
  • [10] Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment
    Moataz Reda
    Worapol Ngamcherdtrakul
    Molly A. Nelson
    Natnaree Siriwon
    Ruijie Wang
    Husam Y. Zaidan
    Daniel S. Bejan
    Sherif Reda
    Ngoc Ha Hoang
    Noah A. Crumrine
    Justin P. C. Rehwaldt
    Akash Bindal
    Gordon B. Mills
    Joe W. Gray
    Wassana Yantasee
    Nature Communications, 13